VI
DNA.WS

Vestcor Inc’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Vestcor Inc’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed – – 1226
2024
Q2 		$0 Hold
10,000
– – ﹤0.01% 1306
2024
Q1 		$1K Hold
10,000
– – ﹤0.01% 1245
2023
Q4 		$1K Hold
10,000
– – ﹤0.01% 1224
2023
Q3 		$2K Hold
10,000
– – ﹤0.01% 1273
2023
Q2 		$3K Hold
10,000
– – ﹤0.01% 1033
2023
Q1 		$2K Hold
10,000
– – ﹤0.01% 1167
2022
Q4 		$2K Hold
10,000
– – ﹤0.01% 1225
2022
Q3 		$7K Hold
10,000
– – ﹤0.01% 1239
2022
Q2 		$5K Hold
10,000
– – ﹤0.01% 1273
2022
Q1 		$9K Hold
10,000
– – ﹤0.01% 1337
2021
Q4 		$22K Hold
10,000
– – ﹤0.01% 1308
2021
Q3 		$34K Buy
+10,000
New +$35.6K ﹤0.01% 1174

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Vestcor Inc's DNA.WS Position: Q3 2024 in Review

Vestcor Inc sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 10,000 shares.

Vestcor Inc first reported a position in DNA.WS in Q3 2021 and held it in 12 quarters. The position peaked at $34K in Q3 2021. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • Vestcor Inc reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • Vestcor Inc sold 10,000 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024.
  • Vestcor Inc first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 12 quarters.
  • Vestcor Inc's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $34K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on Vestcor Inc's 13F filing for Q3 2024, filed 15 Nov 2024.